Imaging technologies for preclinical models of bone and joint disorders
- PMID: 22214535
- PMCID: PMC3251252
- DOI: 10.1186/2191-219X-1-11
Imaging technologies for preclinical models of bone and joint disorders
Abstract
Preclinical models for musculoskeletal disorders are critical for understanding the pathogenesis of bone and joint disorders in humans and the development of effective therapies. The assessment of these models primarily relies on morphological analysis which remains time consuming and costly, requiring large numbers of animals to be tested through different stages of the disease. The implementation of preclinical imaging represents a keystone in the refinement of animal models allowing longitudinal studies and enabling a powerful, non-invasive and clinically translatable way for monitoring disease progression in real time. Our aim is to highlight examples that demonstrate the advantages and limitations of different imaging modalities including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), single-photon emission computed tomography (SPECT) and optical imaging. All of which are in current use in preclinical skeletal research. MRI can provide high resolution of soft tissue structures, but imaging requires comparatively long acquisition times; hence, animals require long-term anaesthesia. CT is extensively used in bone and joint disorders providing excellent spatial resolution and good contrast for bone imaging. Despite its excellent structural assessment of mineralized structures, CT does not provide in vivo functional information of ongoing biological processes. Nuclear medicine is a very promising tool for investigating functional and molecular processes in vivo with new tracers becoming available as biomarkers. The combined use of imaging modalities also holds significant potential for the assessment of disease pathogenesis in animal models of musculoskeletal disorders, minimising the use of conventional invasive methods and animal redundancy.
Figures






Similar articles
-
More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003
-
Preclinical imaging: an essential ally in modern biosciences.Mol Diagn Ther. 2014 Apr;18(2):153-73. doi: 10.1007/s40291-013-0062-3. Mol Diagn Ther. 2014. PMID: 24146172 Review.
-
Anaesthesia and physiological monitoring during in vivo imaging of laboratory rodents: considerations on experimental outcomes and animal welfare.EJNMMI Res. 2012 Aug 9;2(1):44. doi: 10.1186/2191-219X-2-44. EJNMMI Res. 2012. PMID: 22877315 Free PMC article.
-
Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis.Ont Health Technol Assess Ser. 2010;10(8):1-64. Epub 2010 Jun 1. Ont Health Technol Assess Ser. 2010. PMID: 23074411 Free PMC article.
-
The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.Semin Nucl Med. 2006 Oct;36(4):286-94. doi: 10.1053/j.semnuclmed.2006.05.001. Semin Nucl Med. 2006. PMID: 16950146 Review.
Cited by
-
Longitudinal in vivo evaluation of bone regeneration by combined measurement of multi-pinhole SPECT and micro-CT for tissue engineering.Sci Rep. 2015 May 19;5:10238. doi: 10.1038/srep10238. Sci Rep. 2015. PMID: 25989250 Free PMC article.
-
Evaluation of longitudinal time-lapsed in vivo micro-CT for monitoring fracture healing in mouse femur defect models.Sci Rep. 2019 Nov 25;9(1):17445. doi: 10.1038/s41598-019-53822-x. Sci Rep. 2019. PMID: 31768003 Free PMC article.
-
(18)F-FDG microPET imaging differentiates between septic and aseptic wound healing after orthopedic implant placement: a longitudinal study of an implant osteomyelitis in the rabbit tibia.Acta Orthop. 2014 Jun;85(3):305-13. doi: 10.3109/17453674.2014.900894. Epub 2014 Mar 27. Acta Orthop. 2014. PMID: 24673540 Free PMC article.
-
Exploring a Nitric Oxide-Releasing Celecoxib Derivative as a Potential Modulator of Bone Healing: Insights from Ex Vivo and In Vivo Imaging Experiments.Int J Mol Sci. 2025 Mar 13;26(6):2582. doi: 10.3390/ijms26062582. Int J Mol Sci. 2025. PMID: 40141223 Free PMC article.
-
Hallmarks of frailty and osteosarcopenia in prematurely aged PolgA(D257A/D257A) mice.J Cachexia Sarcopenia Muscle. 2020 Aug;11(4):1121-1140. doi: 10.1002/jcsm.12588. Epub 2020 Jun 28. J Cachexia Sarcopenia Muscle. 2020. PMID: 32596975 Free PMC article.
References
-
- European Science Foundation. Rheumatic Disease-a Major Challenge for European Research and Health Care. European Science Foundation Policy Briefing. 2006;6:1–4.
-
- Vanderheyden JL. The use of imaging in preclinical drug development. Q J Nucl Med Mol Imaging. 2009;53:374–381. - PubMed
-
- Holdsworth DW, Thornton M. Micro-CT in small animal and specimen imaging. Trends in Biotechnology. 2002;20:34–39. doi: 10.1016/S0167-7799(02)02004-8. - DOI
LinkOut - more resources
Full Text Sources
Other Literature Sources